Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model

Biochemical and Biophysical Research Communications

Volumn 460, Issue 3, 2015, Pages 799-805

  Tian, Yuguang ^a   Zhang, Ying ^a,b   Zhang, Ruoyu ^b   Qiao, Song ^c   Fan, Jing ^b  

^a GUANGDONG FOOD AND DRUG VOCATIONAL COLLEGE   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG HOSPITAL   (China)

Author keywords

Neurodegenerative disease; Parkinson's disease; Resolvin D2; Substantia nigra pars compacta (SNpc)

Indexed keywords

AUTACOID; DOCOSAHEXAENOIC ACID; LIPOPOLYSACCHARIDE; RESOLVIN D2;

ANIMAL; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; METABOLISM; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; PHYSIOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84937760037     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.109     Document Type: Article

References (21)

1. O.A. Levy, C. Malagelada, and L.A. Greene Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps Apoptosis 14 2009 478 500
2. B. Kalyanaraman, V. Darley-Usmar, and K.J. Davies, et al. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations Free Radic. Biol. Med. 52 2012 1 6
3. A.H. Schapira, C.W. Olanow, and J.T. Greenamyre, et al. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives Lancet 384 2014 545 555
4. P.L. McGeer, and E.G. McGeer History of innate immunity in neurodegenerative disorders Front. Pharmacol. 2 2011 77
5. M. Lee, E. McGeer, and P.L. McGeer Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis Neurobiol. Aging 36 2014 42 52
6. H. Zeng, M. Ding, and X.X. Chen, et al. Microglial NADPH oxidase activation mediates rod cell death in the retinal degeneration in rd mice Neuroscience 275 2014 54 61
7. R.P. Liu, M. Zou, and J.Y. Wang, et al. Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling J. Neuroinflamm. 11 2014 47
8. I. Ali, D. Chugh, and C.T. Ekdahl Role of fractalkine-CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain Neurobiol. Dis. 74 2014 194 203
9. M. Zychowska, E. Rojewska, and W. Makuch, et al. The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain Eur. J. Pharmacol. 749 2014 115 123
10. W. Qiu, K. Guo, and L. Yi, et al. Resolvin E1 reduces hepatic fibrosis in mice with infection Exp. Ther. Med. 7 2014 1481 1485
11. Z.Z. Xu, L. Zhang, and T. Liu, et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions Nat. Med. 16 2010 592 597 591pp. following 597
12. Y.P. Sun, S.F. Oh, and J. Uddin Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J. Biol. Chem. 282 2007 9323 9334
13. Y. Jin, M. Arita, and Q. Zhang, et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators Invest. Ophthalmol. Vis. Sci. 50 2009 4743 4752
14. M.K. Jeengar, P.S. Kumar, and D. Thummuri, et al. Review on emu products for use as complementary and alternative medicine Nutrition 31 2015 21 27
15. J. Wu, A. Wang, and Z. Min, et al. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid in vitro and in vivo Biochem. Biophys. Res. Commun. 408 2011 382 387
16. J.Z. Haeggstrom, A. Rinaldo-Matthis, and C.E. Wheelock, et al. Advances in eicosanoid research, novel therapeutic implications Biochem. Biophys. Res. Commun. 396 2010 135 139
17. F. Wu, H.D. Xu, and J.J. Guan, et al. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease Neuroscience 284C 2014 900 911
18. S.V. More, H. Kumar, and I.S. Kim, et al. Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studies CNS Neurol. Disord. Drug Targets 12 2013 680 697
19. J.A. Garcia, S.M. Cardona, and A.E. Cardona Isolation and analysis of mouse microglial cells Curr. Protoc. Immunol. 104 2014 Unit 1435
20. M. Veeravigrom, T. Desudchit, and K. Chomtho, et al. Neurodegeneration with brain iron accumulation disorder mimics autism Pediatr. Neurol. 51 2014 862 863
21. J.J. Young, D. Bruno, and N. Pomara A review of the relationship between proinflammatory cytokines and major depressive disorder J. Affect. Disord. 169 2014 15 20